107 related articles for article (PubMed ID: 23285938)
21. [Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].
Wei X; Xie YM
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2748-51. PubMed ID: 23285926
[TBL] [Abstract][Full Text] [Related]
22. [Security revaluation study based on nested case-control method of Danhong injection].
Li CX; Tang JF; Meng F; Li XL
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2735-8. PubMed ID: 23285922
[TBL] [Abstract][Full Text] [Related]
23. [Clinical outcomes research on parenterally administered kudiezi in treatment of cerebral infarction].
Chang YP; Li L; Xie YM; Zhuang Y
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3155-60. PubMed ID: 24471344
[TBL] [Abstract][Full Text] [Related]
24. [Adverse drug reactions case reports for parenterally administered shuxuening based on analysis of literature].
Ai QH; Wei X; Xie YM; Liao X; Wang ZF
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3190-4. PubMed ID: 24471350
[TBL] [Abstract][Full Text] [Related]
25. [Systematic review of Kudiezi injection drug safety].
Gao SS; Cui RZ; Xie YM; Liao X; Gao XY; Wang JD
Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(12):2380-2390. PubMed ID: 28822197
[TBL] [Abstract][Full Text] [Related]
26. [Apply association rules to analysis adverse drug reactions of shuxuening injection based on spontaneous reporting system data].
Yang W; Xie YM; Xiang YY
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3616-20. PubMed ID: 25532406
[TBL] [Abstract][Full Text] [Related]
27. [Chinese medicine adverse reactions' literature statistical analysis in recent five years].
Xiang F; Zhang X
Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2755-8. PubMed ID: 22242443
[TBL] [Abstract][Full Text] [Related]
28. [Use propensity score method to analyze data about effectiveness of coronary heart disease treated by kudiezi injection].
Liao X; Zeng XB; Xie YM; Yang W; Yang W
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3172-9. PubMed ID: 24471347
[TBL] [Abstract][Full Text] [Related]
29. [Systematic report on re-evaluating kudiezi injection].
Liao X; Hua GQ; Xie YM; Liu DH
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3626-9. PubMed ID: 25532408
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of kudiezi injection different dosage impact on patient's liver and kidney function based on hospital information system].
Liao X; Tang H; Xie YM; Yang W; Ai QH
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3585-92. PubMed ID: 25532401
[TBL] [Abstract][Full Text] [Related]
31. [Reevaluation on adverse reaction monitoring and safety of proprietary Chinese medicines of Chongqing from 2005 to 2011].
Yang YY; Dong Z; Zhu SB; Sun HF; Yang MP
Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3659-63. PubMed ID: 23477159
[TBL] [Abstract][Full Text] [Related]
32. Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy.
Kim MH; Lin J; Hussein M; Battleman D
Curr Med Res Opin; 2009 Dec; 25(12):3037-47. PubMed ID: 19852699
[TBL] [Abstract][Full Text] [Related]
33. [Observations and countermeasures on adverse reaction of acupoint sticking used treating winter disease in summer].
Li L; Song DY; Xu LH
Zhongguo Zhen Jiu; 2012 Feb; 32(2):162. PubMed ID: 22493926
[No Abstract] [Full Text] [Related]
34. [Study of clinical dose of Xiyanping injection based on HIS data].
Wang ZF; Xie YM
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2727-9. PubMed ID: 23285920
[TBL] [Abstract][Full Text] [Related]
35. [Reasonable and safe application of Shuxuetong injection and intravenous medication's combined application in acute cerebral infarction's therapy].
Li MQ; Xie YM; Zhao JJ
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2742-3. PubMed ID: 23285924
[TBL] [Abstract][Full Text] [Related]
36. [Research and implementation of adverse reaction automatic warning algorithm on Chinese medicine injection].
Zhuang Y; Xie BT; Xie YM; Weng SX
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2695-7. PubMed ID: 23285911
[TBL] [Abstract][Full Text] [Related]
37. [Incidence rate of adverse reaction/event by Qingkailing injection: a Meta-analysis of single rate].
Ai CL; Xie YM; Li MQ; Wang LX; Liao X
Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4770-8. PubMed ID: 27245021
[TBL] [Abstract][Full Text] [Related]
38. [Method and meaning research on skin-test of four injections of traditional Chinese medicine].
Weng WL; Lin HS; Gao R; Chen CH
Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(24):2649-52. PubMed ID: 18338608
[TBL] [Abstract][Full Text] [Related]
39. [Study of post marketing safety reevaluation of shenqi fuzheng injection].
Ai QH; Li YY; Xie YM
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3633-6. PubMed ID: 25532410
[TBL] [Abstract][Full Text] [Related]
40. [Comparison and analysis of clinical safety evaluation methods for parenterally administered Chinese medicine].
Yan BH; Peng C; Xie YM; Wang YY
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2979-82. PubMed ID: 24471315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
